These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 16987075)

  • 1. Concentrations of soluble Fas and soluble Fas ligand as indicators of programmed cell death among patients coinfected with Human Immunodeficiency Virus and Hepatitis C Virus.
    Lapinski TW; Jaroszewicz J; Wiercinska-Drapalo A
    Viral Immunol; 2006; 19(3):570-5. PubMed ID: 16987075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased soluble Fas in HIV-infected hemophilia patients with CD4+ and CD8+ cell count increases and viral load and immune complex decreases.
    Daniel V; Süsal C; Weimer R; Zimmermann R; Huth-Kühne A; Opelz G
    AIDS Res Hum Retroviruses; 2001 Mar; 17(4):329-35. PubMed ID: 11242519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concentrations of ssDNA in liver tissue and its correlation with sFas and sFasL in serum of patients infected with HBV, HCV, HCV and HIV.
    Łapinski TW; Wiercińska-Drapało A; Panasiuk A; Kovalchuk O
    Adv Med Sci; 2007; 52():109-13. PubMed ID: 18217400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of soluble FAS, FAS ligand and tumour necrosis factor-alpha in patients with chronic HCV infection.
    Raghuraman S; Abraham P; Daniel HD; Ramakrishna BS; Sridharan G
    J Clin Virol; 2005 Sep; 34(1):63-70. PubMed ID: 16087126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C coinfection enhances sensitization of CD4(+) T-cells towards Fas-induced apoptosis in viraemic and HAART-controlled HIV-1-positive patients.
    Körner C; Tolksdorf F; Riesner K; Krämer B; Schulte D; Nattermann J; Rockstroh JK; Spengler U
    Antivir Ther; 2011; 16(7):1047-55. PubMed ID: 22024520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association among Fas expression in leucocytes, serum Fas and Fas-ligand concentrations and hepatic inflammation and fibrosis in chronic hepatitis C.
    Panasiuk A; Parfieniuk A; Zak J; Flisiak R
    Liver Int; 2010 Mar; 30(3):472-8. PubMed ID: 19919570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of apoptotic markers among human immunodeficiency virus (HIV-1) infected individuals.
    Ramalingam S; Kannangai R; Abraham OC; Subramanian S; Rupali P; Pulimood SA; Jesudason MV; Sridharan G
    Indian J Med Res; 2008 Dec; 128(6):728-33. PubMed ID: 19246796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased hepatocyte fas expression and apoptosis in HIV and hepatitis C virus coinfection.
    Macias J; Japón MA; Sáez C; Palacios RB; Mira JA; García-García JA; Merchante N; Vergara S; Lozano F; Gómez-Mateos J; Pineda JA
    J Infect Dis; 2005 Nov; 192(9):1566-76. PubMed ID: 16206071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble Fas and Fas ligand in HIV/HCV coinfected patients and impact of HCV therapy.
    Guzmán-Fulgencio M; Berenguer J; García-Álvarez M; Micheloud D; C López J; Cosín J; Fernández de Castro I; Catalán P; Miralles P; Resino S
    Eur J Clin Microbiol Infect Dis; 2011 Oct; 30(10):1213-21. PubMed ID: 21442358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variations in the serum concentrations of soluble Fas and soluble Fas ligand in Vietnamese patients infected with hepatitis B virus.
    Song le H; Binh VQ; Duy DN; Bock TC; Kremsner PG; Luty AJ; Mavoungou E
    J Med Virol; 2004 Jun; 73(2):244-9. PubMed ID: 15122799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical significances of serum soluble fas and soluble fas ligand in chronic hepatitis B].
    Jun EJ; Han JY; Sun HS
    Korean J Hepatol; 2006 Dec; 12(4):507-14. PubMed ID: 17237628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [An investigation of clinical features and immunological functions of HCV-specific cytotoxic T lymphocytes in HIV/HCV co-infected patients].
    DU XF; Zhang YH; Ma LN; Yan HP; Chen XY; Wu H
    Zhonghua Gan Zang Bing Za Zhi; 2008 May; 16(5):345-8. PubMed ID: 18510845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic compartmentalization of exhausted and regulatory cells in HIV/HCV-coinfected patients.
    Barrett L; Trehanpati N; Poonia S; Daigh L; Sarin SK; Masur H; Kottilil S
    J Viral Hepat; 2015 Mar; 22(3):281-8. PubMed ID: 25174689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progression of chronic hepatitis C to liver fibrosis and cirrhosis in patients coinfected with hepatitis C virus and human immunodeficiency virus.
    Martinez-Sierra C; Arizcorreta A; Díaz F; Roldán R; Martín-Herrera L; Pérez-Guzmán E; Girón-González JA
    Clin Infect Dis; 2003 Feb; 36(4):491-8. PubMed ID: 12567308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum soluble Fas (CD95) and Fas ligand profiles in chronic kidney failure.
    Perianayagam MC; Murray SL; Balakrishnan VS; Guo D; King AJ; Pereira BJ; Jaber BL
    J Lab Clin Med; 2000 Oct; 136(4):320-7. PubMed ID: 11039853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the impact of hepatitis C virus (HCV) on highly active antiretroviral therapy-mediated immune responses in HCV/HIV-coinfected women: role of HCV on expression of primed/memory T cells.
    Al-Harthi L; Voris J; Du W; Wright D; Nowicki M; Frederick T; Landay A; Kovacs A
    J Infect Dis; 2006 May; 193(9):1202-10. PubMed ID: 16586355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cryoglobulinaemia vasculitis in patients coinfected with HIV and hepatitis C virus.
    Saadoun D; Aaron L; Resche-Rigon M; Pialoux G; Piette JC; Cacoub P;
    AIDS; 2006 Apr; 20(6):871-7. PubMed ID: 16549971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stable recovery from HCV in HIV-HCV co-infection under antiretroviral therapy.
    Zeitoun JD; Mallet V; Chaix ML; Viard JP; Blanche S; Pol S
    J Clin Virol; 2007 Sep; 40(1):71-3. PubMed ID: 17658294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of hepatitis C virus coinfection on T-cell dynamics in long-term HIV-suppressors under combined antiretroviral therapy.
    Zaegel-Faucher O; Bregigeon S; Cano CE; Obry-Roguet V; Nicolino-Brunet C; Tamalet C; Dignat-George F; Poizot-Martin I
    AIDS; 2015 Jul; 29(12):1505-10. PubMed ID: 26244390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus load is associated with human immunodeficiency virus type 1 disease progression in hemophiliacs.
    Daar ES; Lynn H; Donfield S; Gomperts E; O'Brien SJ; Hilgartner MW; Hoots WK; Chernoff D; Arkin S; Wong WY; Winkler CA;
    J Infect Dis; 2001 Feb; 183(4):589-95. PubMed ID: 11170984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.